SEC Form 4 · accession 0001553350-16-001860
HEAT BIOLOGICS, INC. · HTBX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ann A Rosar
Officer — VP of Finance and Controller
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 9:47 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001476963
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $0.66 | Apr 5, 2016 | A | 20,000 | A | Apr 5, 2016 | Apr 4, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The reporting person was granted an incentive option to purchase an aggregate of twenty thousand (20,000) shares of the Company's common stock pursuant to the Company's Amended and Restated 2014 Stock Incentive Plan at an exercise price of $0.66 per share. These options are exercisable over a ten (10) year period, vesting monthly on a pro rate basis over a four (4) year period.